Читаем Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний полностью

Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

Бастиан Блоэм , Майкл Окун , Рэй Дорси , Тодд Шерер

83. FAQs about the FDA Patient Representative Program. US Food and Drug Administration. www.fda.gov/ForPatients/ucm412529.htm. Updated May 12, 2018. Accessed March 19, 2019.

84. Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80(21):1989–1996; Rosenthal E. An American Sickness: How Healthcare Became Big Business and How You Can Take It Back. 1st ed. Penguin Press; 2017.

85. Historical evolution of FDA advisory committees. In: Rettig RA, Earley LE, Merill RA, eds. Institute of Medicine (US) Committee to Study the Use of Advisory Committees. National Academies Press; 1992.

<p>Глава 8: В будущее с оптимизмом</p>

1. FDA approved drugs for neurology. CenterWatch. www.centerwatch. com/drug-information/fda-approved-drugs/therapeutic-area/10/ neurology. Accessed November 29, 2018.

2. Там же.

3. Инструкция по применению: INBRIJA. US Food and Drug Administration. December 2018. www.accessdata.fda.gov/drugsatfda_ docs/label/2018/209184s000lbl.pdf.

4. Инструкция по применению: GOCOVRI. US Food and Drug Administration. August 2017. www.accessdata.fda.gov/drugsatfda_docs/ label/2017/208944lbl.pdf.

5. Инструкция по применению: XADAGO. US Food and Drug Administration. March 2017. www.accessdata.fda.gov/drugsatfda_docs/label/2017/207145lbl.pdf.

6. Инструкция по применению: NUPLAZID. US Food and Drug Administration. April 2016. www.accessdata.fda.gov/drugsatfda_docs/ label/2016/207318lbl.pdf.

7. Инструкция по применению: DUOPA. US Food and Drug

Administration. September 2016. www.rxabbvie.com/pdf/duopa_pi.pdf.

8. Инструкция по применению: RYTARY. US Food and Drug

Administration. January 2015. www.accessdata.fda.gov/drugsatfda_docs/ label/2015/203312s000lbl.pdf.

9. Инструкция по применению: NORTHERA. US Food and Drug Administration. February 2014. www.accessdata.fda.gov/drugsatfda_ docs/label/2014/203202lbl.pdf.

10. Novartis. Инструкция по применению: EXELON. US Food and Drug Administration. December 2018. www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/ files/exelon.pdf.

11. Инструкция по применению: NEUPRO. US Food and Drug Administration. April 2012. www.accessdata.fda.gov/drugsatfda_docs/ label/2012/021829s001lbl.pdf.

12. Инструкция по применению: APOKYN. US Food and Drug Administration. July 2014. www.accessdata.fda.gov/drugsatfda_docs/ label/2014/021264s010lbl.pdf.

13. Novartis. Инструкция по применению: COMTAN. US Food and Drug Administration. September 28, 2010. www.accessdata.fda.gov/ drugsatfda_docs/label/2010/020796s15lbl.pdf.

14. FDA approved drugs for neurology. CenterWatch. www.centerwatch. com/drug-information/fda-approved-drugs/therapeutic-area/10/ neurology. Accessed November 29, 2018.

15. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine. 2006;355(9):896–908.

16. Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harbor Perspectives in Medicine. 2011;1(1):a008862; Wagle Shukla A, Okun MS. Surgical treatment of Parkinson’s disease: patients, targets, devices, and approaches. Neurotherapeutics. 2014;11(1):47–59.

17. Wagle Shukla A, Okun MS. Surgical treatment of Parkinson’s disease: patients, targets, devices, and approaches. Neurotherapeutics. 2014;11(1):47–59.

18. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. In: Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP, eds. Progress in Brain Research. Vol 85. Elsevier; 1991:119–146; Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience. 1986;9(1):357–381.

19. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Stereotactic and Functional Neurosurgery. 1987;50(1–6):344–346.

20. Lozano AM, Eltahawy H. How does DBS work? Supplement to Clinical Neurophysiology. 2004;57:733–736.

Перейти на страницу: